1. Home
  2. GOSS vs MEI Comparison

GOSS vs MEI Comparison

Compare GOSS & MEI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • GOSS
  • MEI
  • Stock Information
  • Founded
  • GOSS 2015
  • MEI 1946
  • Country
  • GOSS United States
  • MEI United States
  • Employees
  • GOSS N/A
  • MEI N/A
  • Industry
  • GOSS Biotechnology: Pharmaceutical Preparations
  • MEI Electrical Products
  • Sector
  • GOSS Health Care
  • MEI Technology
  • Exchange
  • GOSS Nasdaq
  • MEI Nasdaq
  • Market Cap
  • GOSS 347.8M
  • MEI 231.0M
  • IPO Year
  • GOSS 2019
  • MEI N/A
  • Fundamental
  • Price
  • GOSS $2.47
  • MEI $7.66
  • Analyst Decision
  • GOSS Strong Buy
  • MEI Buy
  • Analyst Count
  • GOSS 4
  • MEI 2
  • Target Price
  • GOSS $8.50
  • MEI $10.50
  • AVG Volume (30 Days)
  • GOSS 3.1M
  • MEI 404.9K
  • Earning Date
  • GOSS 08-05-2025
  • MEI 09-03-2025
  • Dividend Yield
  • GOSS N/A
  • MEI 3.62%
  • EPS Growth
  • GOSS N/A
  • MEI N/A
  • EPS
  • GOSS N/A
  • MEI N/A
  • Revenue
  • GOSS $40,237,000.00
  • MEI $1,048,100,000.00
  • Revenue This Year
  • GOSS N/A
  • MEI N/A
  • Revenue Next Year
  • GOSS $30.65
  • MEI $0.44
  • P/E Ratio
  • GOSS N/A
  • MEI N/A
  • Revenue Growth
  • GOSS N/A
  • MEI N/A
  • 52 Week Low
  • GOSS $0.66
  • MEI $5.08
  • 52 Week High
  • GOSS $2.65
  • MEI $17.45
  • Technical
  • Relative Strength Index (RSI)
  • GOSS 68.08
  • MEI 63.37
  • Support Level
  • GOSS $2.38
  • MEI $6.52
  • Resistance Level
  • GOSS $2.65
  • MEI $7.83
  • Average True Range (ATR)
  • GOSS 0.15
  • MEI 0.28
  • MACD
  • GOSS 0.03
  • MEI 0.18
  • Stochastic Oscillator
  • GOSS 76.67
  • MEI 90.14

About GOSS Gossamer Bio Inc.

Gossamer Bio Inc is a clinical-stage biopharmaceutical company. It focuses on discovering, acquiring, developing, and commercializing therapeutics in the disease areas of immunology, inflammation, and oncology. The company pipeline products include Seralutinib, which address the cellular overgrowth, fibrosis, and vascular remodeling which underlie PAH (pulmonary arterial hypertension); GB004, for the treatment of inflammatory bowel disease, including ulcerative colitis and Crohn's disease; GB1275, for the treatment of oncology indications; and GB001, for the treatment of moderate-to-severe eosinophilic asthma.

About MEI Methode Electronics Inc.

Methode Electronics Inc supplier of custom-engineered solutions with sales, engineering, and manufacturing locations in North America, Europe, the Middle East, and Asia. It designs, engineers, and produces mechatronic products for Original Equipment Manufacturers (OEMs) utilizing a broad range of technologies for user interface, light-emitting diode (LED) lighting systems, power distribution, and sensor applications. The firm is organized into various business segments: Automotive, Industrial, Interface, and Medical. The Automotive segment, which generates maximum revenue, supplies electronic and electro-mechanical devices and related products to automobiles, including overhead and center consoles, hidden and ergonomic switches, insert molded components, LED-based lighting, and sensors.

Share on Social Networks: